Clinical Trial Details
| Trial ID: | L4731 |
| Source ID: | NCT00657943 |
| Associated Drug: | Metformin |
| Title: | The Copenhagen Insulin and Metformin Therapy Trial |
| Acronym: | CIMT |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes|Atherosclerosis|Arteriosclerosis |
| Interventions: | DRUG: metformin|DRUG: insulin detemir|DRUG: insulin aspart + insulin aspart protamin|DRUG: Insulin aspart |
| Outcome Measures: | Primary: Carotid intima media thickness, 18 months | Secondary: adverse events, 18 months |
| Sponsor/Collaborators: | Sponsor: Steno Diabetes Center Copenhagen | Collaborators: Hvidovre University Hospital|Hillerod Hospital, Denmark|Frederiksberg University Hospital|University Hospital, Gentofte, Copenhagen|Rigshospitalet, Denmark|Bispebjerg Hospital|Herlev Hospital|Zealand University Hospital|Copenhagen Trial Unit, Center for Clinical Intervention Research|Novo Nordisk A/S |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 415 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT |
| Start Date: | 2008-04 |
| Completion Date: | 2012-12 |
| Results First Posted: | |
| Last Update Posted: | 2014-02-04 |
| Locations: | Rigshospitalet, Copenhagen, 2100, Denmark|Bispebjerg Hospital, Copenhagen, 2400, Denmark|Frederiksberg Hospital, Frederiksberg, 2000, Denmark|Gentofte Sygehus, Gentofte, 2820, Denmark|Steno Diabetes Center, Gentofte, 2820, Denmark|Herlev Hospital, Herlev, 2830, Denmark|Hillerod Sygehus, Hillerod, 3400, Denmark|Hvidovre Hospital, Hvidovre, 2650, Denmark|Køge Sygehus, Koge, 4600, Denmark |
| URL: | https://clinicaltrials.gov/show/NCT00657943 |
